Elevated CRP levels have been associated with several adverse disease features and a shorter leukemia-free survival [5,6], and albumin has been consistently shown to add additional prognostic information independently of DIPSS and several DIPSS-based prognostic scoring systems [7,8,9]. This evidence concerns the gene CRP and leukemia.